CELU vs. ATIP, LOTZ, CMAX, MVST, IMMP, STTK, ABOS, PRLD, GBIO, and VTYX
Should you be buying Celularity stock or one of its competitors? The main competitors of Celularity include ATI Physical Therapy (ATIP), CarLotz (LOTZ), CareMax (CMAX), Microvast (MVST), Immutep (IMMP), Shattuck Labs (STTK), Acumen Pharmaceuticals (ABOS), Prelude Therapeutics (PRLD), Generation Bio (GBIO), and Ventyx Biosciences (VTYX).
Celularity (NASDAQ:CELU) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability.
Celularity has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500.
ATI Physical Therapy received 7 more outperform votes than Celularity when rated by MarketBeat users. However, 42.11% of users gave Celularity an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
Celularity has a net margin of 0.00% compared to ATI Physical Therapy's net margin of -8.15%.
19.0% of Celularity shares are owned by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are owned by institutional investors. 20.7% of Celularity shares are owned by insiders. Comparatively, 3.3% of ATI Physical Therapy shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, ATI Physical Therapy had 1 more articles in the media than Celularity. MarketBeat recorded 3 mentions for ATI Physical Therapy and 2 mentions for Celularity. Celularity's average media sentiment score of 0.63 beat ATI Physical Therapy's score of 0.33 indicating that Celularity is being referred to more favorably in the media.
Celularity has higher earnings, but lower revenue than ATI Physical Therapy.
Summary
Celularity beats ATI Physical Therapy on 8 of the 12 factors compared between the two stocks.
Get Celularity News Delivered to You Automatically
Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CELU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Celularity Competitors List
Related Companies and Tools
